News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Warns On Hospira, Inc., Abbott Laboratories (ABT) Infusion Pump Recall


5/5/2014 7:22:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The FDA put their highest-risk warning on a recall of infusion pumps by Hospira (NYSE:HSP) and Abbott (NYSE:ABT), saying that a broken door assembly may cause an over- or under-infusion of drug therapy. The FDA noted that Hospira had received customer complaints about the Abbott Acclaim infusion pumps and the Hospira Acclaim Encore infusion pumps. The devices are used to deliver a range of therapies, including whole blood, medicines and nutritional fluids.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES